The present invention relates to the novel use of arylalkanolamine compounds with sigma-1 receptor antagonist activity. In particular, the said arylalkanolamine compounds are useful in the treatment of conditions such as, for example, the abuse of psychotropic substances such as cocaine or amphetamines, pain and cancer.

Use of arylalkanolamines as sigma-1 receptor antagonists

COLLINA, SIMONA;ROSSI, DANIELA;MARRA, ANNAMARIA;PEVIANI, MARCO;CURTI, DANIELA
2015

Abstract

The present invention relates to the novel use of arylalkanolamine compounds with sigma-1 receptor antagonist activity. In particular, the said arylalkanolamine compounds are useful in the treatment of conditions such as, for example, the abuse of psychotropic substances such as cocaine or amphetamines, pain and cancer.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11571/1182589
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact